SCHEMBL323739

SCHEMBL323739

[CH2]CSC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1879803 0.75
SCHEMBL8044195 0.73
SCHEMBL22551299 0.72 CYP2C19 (0.60)
SCHEMBL6444227 0.72
SCHEMBL1885262 0.71
SCHEMBL18487168 0.71 CYP2C19 (0.40)
SCHEMBL2289375 0.69
SCHEMBL10403366 0.69
SCHEMBL15791167 0.69
SCHEMBL10403365 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116916963-A Multivalent ligand clusters with diamine scaffolds for targeted delivery of therapeutic agents 上海舶望制药有限公司 2023-10-20 CN claimed
US-11597926-B2 Thiophosphoramidites ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2023-03-07 US claimed
CN-114206389-A Multivalent ligand clusters for targeted delivery of therapeutic agents 有丝分裂疗法有限责任公司 2022-03-18 CN claimed
EP-3923989-A1 MULTIVALENT LIGAND CLUSTERS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS Mitotherapeutix LLC (US) 2021-12-22 EP claimed
US-20210115438-A1 NOVEL THIOPHOSPHORAMIDITES ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2021-04-22 US claimed
EP-3728590-A1 NOVEL THIOPHOSPHORAMIDITES Roche Innovation Center Copenhagen A/S (DK) 2020-10-28 EP claimed
WO-2020191183-A1 MULTIVALENT LIGAND CLUSTERS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS MITOTHERAPEUTIX LLC (US) 2020-09-24 WO claimed
CN-111448316-A Novel thiophosphorous acid amides 罗氏创新中心哥本哈根有限公司 2020-07-24 CN claimed
EP-3484908-A1 NON-NUCLEOSIDIC SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS AM Chemicals Llc (US) 2019-05-22 EP claimed
US-20180125986-A1 Nitric Oxide Releasing Produgs of Therapeutic Agents SATYAM APPARAO (IN) 2018-05-10 US claimed
US-4235920-A ANTIBIOTICS MERCK & CO., INC. (US) 1980-11-25 US claimed
US-4235917-A N-Alkyl-N-acyl derivatives of thienamycin MERCK & CO., INC. (US) 1980-11-25 US claimed
US-4232030-A ANTIBIOTICS MERCK & CO., INC. (US) 1980-11-04 US claimed
US-4196211-A ANTIBIOTIC MERCK & CO., INC. (US) 1980-04-01 US claimed
US-4181733-A ANTIBIOTICS MERCK & CO., INC. (US) 1980-01-01 US claimed
EP-0001264-A1 Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation MERCK & CO. INC. (US) 1979-04-04 EP claimed
EP-0001265-A1 O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds MERCK & CO. INC. (US) 1979-04-04 EP claimed
US-4078068-A ANTIBIOTICS MERCK & CO., INC. (US) 1978-03-07 US claimed
US-4078067-A ANTIBIOTICS MERCK & CO., INC. (US) 1978-03-07 US claimed
US-4076826-A ANTIBIOTIC MERCK & CO., INC. (US) 1978-02-28 US claimed